{"id":"https://openalex.org/W2369729409","doi":null,"title":"The Percentages of Achieving Lipid-lowing Targets and the Safety of Different Starting Doses of Atorvastatin in Hypercholesterol Patients of Different Cardiovascular Risk Stratifications","display_name":"The Percentages of Achieving Lipid-lowing Targets and the Safety of Different Starting Doses of Atorvastatin in Hypercholesterol Patients of Different Cardiovascular Risk Stratifications","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W2369729409","mag":"2369729409"},"language":"en","primary_location":{"id":"mag:2369729409","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-KDYZ201309016.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764612545","display_name":"Chinese Journal of Arteriosclerosis","issn_l":"1007-3949","issn":["1007-3949"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4353108606","host_organization_name":"Chinese Society of Pathophysiology","host_organization_lineage":["https://openalex.org/P4353108606"],"host_organization_lineage_names":["Chinese Society of Pathophysiology"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Arteriosclerosis","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Yang Ju","orcid":"https://orcid.org/0000-0003-4297-4455","observed_orcids":["https://orcid.org/0000-0003-4297-4455"]},"institutions":[{"id":"https://openalex.org/I4210160344","display_name":"Tongji Hospital","ror":"https://ror.org/04xy45965","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210160344"]},{"id":"https://openalex.org/I47720641","display_name":"Huazhong University of Science and Technology","ror":"https://ror.org/00p991c53","country_code":"CN","type":"education","lineage":["https://openalex.org/I47720641"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yang Ju","raw_affiliation_strings":["Department of Gerontology,Tongji Hospital Affiliated to Tongji Medical College,Huazhong University of Science and Technology"],"raw_orcid":"https://orcid.org/0000-0003-4297-4455","affiliations":[{"raw_affiliation_string":"Department of Gerontology,Tongji Hospital Affiliated to Tongji Medical College,Huazhong University of Science and Technology","institution_ids":["https://openalex.org/I4210160344","https://openalex.org/I47720641"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210160344","https://openalex.org/I47720641"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33557038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/lipid-lowering-targets","display_name":"lipid-lowering targets","score":0.7979999780654907},{"id":"https://openalex.org/keywords/cardiovascular-risk-stratification","display_name":"cardiovascular risk stratification","score":0.8610000014305115},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6639999747276306},{"id":"https://openalex.org/keywords/starting-dose","display_name":"starting dose","score":0.5600000023841858},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.6269999742507935},{"id":"https://openalex.org/keywords/statin-safety","display_name":"statin safety","score":0.8730000257492065},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.9416511058807373},{"id":"https://openalex.org/C162156334","wikidata":"https://www.wikidata.org/wiki/Q473420","display_name":"Dose","level":2,"score":0.7486262321472168},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7374544143676758},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5461025834083557},{"id":"https://openalex.org/C2778270857","wikidata":"https://www.wikidata.org/wiki/Q2723972","display_name":"Lipid profile","level":3,"score":0.44198018312454224},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3993634283542633},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3630898594856262}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2369729409","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-KDYZ201309016.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764612545","display_name":"Chinese Journal of Arteriosclerosis","issn_l":"1007-3949","issn":["1007-3949"],"is_oa":false,"is_in_doaj":true,"is_core":false,"listed_in":["doaj"],"host_organization":"https://openalex.org/P4353108606","host_organization_name":"Chinese Society of Pathophysiology","host_organization_lineage":["https://openalex.org/P4353108606"],"host_organization_lineage_names":["Chinese Society of Pathophysiology"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Chinese Journal of Arteriosclerosis","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1764668080","https://openalex.org/W4406077278","https://openalex.org/W2417262914","https://openalex.org/W2111065997","https://openalex.org/W2343722442","https://openalex.org/W2006071670","https://openalex.org/W2740350083","https://openalex.org/W2039325578","https://openalex.org/W1863726591","https://openalex.org/W2399596935"],"abstract_inverted_index":{"Aim":[0],"To":[1],"evaluate":[2],"the":[3,10,64,86,95,108,214,253,286,314,320,326],"percentages":[4,236,254,315],"of":[5,12,15,20,41,88,104,131,154,160,193,204,233,237,248,255,267,273,285,300,316,322,328],"achieving":[6,205,238,256,274,317],"lipid-lowing":[7,126,206,239,257,275,318,330],"targets":[8,127,171,207,240,258],"and":[9,54,78,114,188,201,222,231,246,264,292,308],"safety":[11],"different":[13,21,101],"doses":[14],"atorvastatin":[16,105,135,161],"in":[17,29,39,58,63,94,144,190,198,250,269,277,289],"hypercholesterol":[18],"patients":[19,33,57,93,141],"cardiovascular":[22,90,116,305],"risk":[23,66,70,74,81,91,117,216,218,220,225,306],"stratifications.Methods":[24],"From":[25],"February":[26],"to":[27,85,107,303],"July":[28],"2012,we":[30],"enrolled":[31,150],"122":[32],"who":[34,148],"were":[35,48,61,99,139,149,156,208,259],"diagnosed":[36],"as":[37,44,151],"hypercholesterolemia":[38,143],"outpatient":[40],"our":[42],"hospital":[43],"experimental":[45,59,194,251,278],"group,and":[46],"they":[47],"50":[49],"~70":[50],"years":[51],"old,77":[52],"men":[53],"45":[55],"female.All":[56],"group":[60,195,221,226,288],"assigned":[62],"low":[65,109,215],"group(n":[67,71,75,82],"=":[68,72,76,83],"29),intermediate":[69],"33),high":[73],"32)":[77],"very":[79,223],"high":[80,224],"28)according":[84],"stratifications":[87,307],"their":[89,115],"factors.The":[92],"above":[96],"four":[97,191],"groups":[98,192,279],"given":[100,157],"initial":[102,298],"dosages":[103,299,321],"according":[106,302],"density":[110],"lipoprotein":[111],"cholesterol(LDLC)":[112],"levels":[113,123,310],"stratifications,and":[118],"for":[119,164],"those":[120,165],"whose":[121,166],"LDLC":[122,167,189],"didn't":[124,168],"achieve":[125,169],"after":[128,228],"6":[129,199,229,244,262,290],"weeks":[130,200,230,245,263,266,291],"treatment":[132,249,268,331],"10":[133,172],"mg":[134,173],"would":[136,175],"be":[137,176,333],"added.There":[138],"39":[140],"with":[142],"that":[145,284],"same":[146],"period":[147,181],"control":[152,270,287],"group,all":[153],"them":[155],"routine":[158],"dosage":[159],"every":[162,178],"day,and":[163],"lip-id-lowing":[170],"atovastatin":[174,301,323],"added":[177],"day.The":[179],"study":[180],"was":[182,241,280],"12":[183,265,293],"weeks.Results":[184],"The":[185],"total":[186,235],"cholesterol":[187,309],"decreased":[196],"significantly":[197,282,313],"12weeks.The":[202],"percentage":[203,272],"75.9%vs":[209],"89.7%,72.7%vs":[210],"81.8%,71.9%vs":[211],"78.1%,57.1%vs":[212],"71.4%in":[213],"group,intermediate":[217],"group,high":[219],"respectively":[227],"12weeks":[232,247],"treatment.The":[234],"69.7%vs":[242],"81.1%after":[243],"group,while":[252],"48.7%vs":[260],"66.7%after":[261],"group.The":[271],"target":[276],"higher":[281],"than":[283],"weeks(P":[294],"0.01,P":[295],"0.05,respectively).Conclusion":[296],"Different":[297],"patients'":[304],"can":[311],"improve":[312],"targets,also":[319],"are":[324],"safe,so":[325],"regimes":[327],"patients-tailored":[329],"should":[332],"popularized.":[334]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}